MDXG

Mimedx Group Stock Analysis

AI Rating

Neutral
  • Quality9/10
  • Growth↓ 1/10
  • Value↑ 5/10
Mimedx Group sales and earnings growth
MDXG Growth
Low
  • Revenue Y/Y↑ 9.62%
  • EPS Y/Y↓ -22.22%
  • FCF Y/Y↑ 7.36%
Mimedx Group gross and profit margin trends
MDXG Profitability
Good
  • Gross margin ↑ 81.00%
  • EPS margin↓ 7.90%
  • ROIC 5Y↑ 41.22%
Mimedx Group net debt vs free cash flow
MDXG Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 16.4

Mimedx Group stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks